The HealthTech Signal
GLP-1 drugs are excellent at losing weight. The muscle question is where healthspan gets decided
GLP-1 drugs are excellent at losing weight. The muscle question is where healthspan gets decided
Dr. Dereck Mush, MD, MBA
Calibrate
Provides clinical weight loss programs combining GLP-1 medications and metabolic coaching.
What they do
Calibrate offers a virtual metabolic reset program designed for long-term weight management. The service combines physician-prescribed GLP-1 medications with lifestyle coaching focusing on sleep, exercise, and nutrition, sold directly to consumers and employers.
The record
- Vertical
- Metabolic Health
- Sub-segment
- Medical weight management
- Product type
- Service
- Stage
- Series B
- Headquarters
- New York, USA
- Region
- North America
- Founded
- 2019
- Total funding
- $160M raised
Notable investors: Founders Fund, Tiger Global Management, Madrona Venture Group.
Also in Metabolic Health
Related on The Signal
Dr. Dereck Mush, MD, MBA
From Remote Telemetry to Active Co-Management: Direct-to-Patient Hemodynamics in Heart Failure
Dr. Dereck Mush, MD, MBA
PCOS care platforms are shifting the conversation from fertility to lifelong metabolic health
Dr. Dereck Mush, MD, MBA
The GLP-1 Data Nobody Puts in the Deck: Adherence, Regain and What Payers Now Model
Dr. Dereck Mush, MD, MBA